The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11

MLA

Wenli Feng, et al. “The Effects of Secreted Aspartyl Proteinase Inhibitor Ritonavir on Azoles‐resistant Strains of Candida Albicans as Well as Regulatory Role of SAP2 and ERG11.” Immunity, Inflammation and Disease, vol. 9, no. 3, Sept. 2021, pp. 667–80. EBSCOhost, https://doi.org/10.1002/iid3.415.

APA

Wenli Feng, Jing Yang, Yan Ma, Zhiqin Xi, Xiaoqin Zhao, Xiaoxia Zhao, & Min Zhao. (2021). The effects of secreted aspartyl proteinase inhibitor ritonavir on azoles‐resistant strains of Candida albicans as well as regulatory role of SAP2 and ERG11. Immunity, Inflammation and Disease, 9(3), 667–680. https://doi.org/10.1002/iid3.415

Chicago

Wenli Feng, Jing Yang, Yan Ma, Zhiqin Xi, Xiaoqin Zhao, Xiaoxia Zhao, and Min Zhao. 2021. “The Effects of Secreted Aspartyl Proteinase Inhibitor Ritonavir on Azoles‐resistant Strains of Candida Albicans as Well as Regulatory Role of SAP2 and ERG11.” Immunity, Inflammation and Disease 9 (3): 667–80. doi:10.1002/iid3.415.